Aeterna Zentaris
AEZS
#10198
Rank
A$26.36 M
Marketcap
A$8.61
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

Earnings for Aeterna Zentaris (AEZS)

Earnings in 2024 (TTM): -A$8.26 Million

According to Aeterna Zentaris's latest financial reports the company's current earnings are A$6.32 Million. In 2023 the company made an earning of -A$5.04 Million a decrease over its 2022 earnings that were of A$5.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aeterna Zentaris from 1997 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$8.26 Million63.91%
2023 -A$5.04 Million-193.05%
2022 A$5.41 M118.42%
2021 A$2.47 M66.11%
2020 A$1.49 M-251.06%
2019 -A$0.99 Million25.51%
2018 -A$0.79 Million72.53%
2017 -A$0.46 Million-109.78%
2016 A$4.66 M49.97%
2015 A$3.11 M61.77%
2014 A$1.92 M597.94%
2013 A$0.27 M-134.11%
2012 -A$0.81 Million-182.25%
2011 A$0.98 M-50.2%
2010 A$1.97 M1084.23%
2009 A$0.16 M-109.18%
2008 -A$1.82 Million-6.23%
2007 -A$1.94 Million752.47%
2006 -A$0.23 Million269.03%
2005 -A$0.07 Million-84.64%
2004 -A$0.41 Million9.96%
2003 -A$0.37 Million184.21%
2002 -A$0.13 Million-69.93%
2001 -A$0.43 Million-22.76%
2000 -A$0.56 Million-13.94%
1999 -A$0.65 Million-31.33%
1998 -A$0.94 Million-84.12%
1997 -A$5.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Spectrum Pharmaceuticals
SPPI
-A$93.17 Million 1,028.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$24.71 B-299,416.93%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
A$12.09 B-146,540.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.70 B-165,996.94%๐Ÿ‡ซ๐Ÿ‡ท France
Halozyme Therapeutics
HALO
A$1.12 B-13,698.38%๐Ÿ‡บ๐Ÿ‡ธ USA